CD3+ T-cell: CD14+monocyte complexes are dynamic and increased with HIV and glucose intolerance
L. M. Obare, J. Simmons, J. Oakes, X. Zhang, C. Nochowivz, S. Priest, S. S. Bailin, C. M. Watten, M. Mashayekhi, H. K. Beasley, J. Shao, L. M. Meenderink, Q. Sheng, J. Stolze, R. Gangula, T. Absi, Y. Ru Su, K. Neikirk, A. Chopra, C. L. Gabriel, T. Temu, S. Pakala, E. M. Wilfong, S. Gianella, E. J. Phillips, , C. N. Wanjalla
Abstract
An increased risk of cardiometabolic disease accompanies persistent systemic inflammation. Yet, the innate and adaptive immune system features in persons who develop these conditions remain poorly defined. Doublets, or cell-cell complexes, are routinely eliminated from flow cytometric and other immune phenotyping analyses, which limits our understanding of their relationship to disease states. Using well-characterized clinical cohorts, including participants with controlled HIV as a model for chronic inflammation and increased immune cell interactions, we show that circulating CD14+ monocytes complexed to CD3+ T cells are dynamic, biologically relevant, and increased in individuals with diabetes after adjusting for confounding factors. The complexes form functional immune synapses with increased expression of proinflammatory cytokines and greater glucose utilization. Furthermore, in persons with HIV, the CD3+T-cell: CD14+monocyte complexes had more HIV copies compared to matched CD14+ monocytes or CD4+ T cells alone. Our results demonstrate that circulating CD3+T-cell:CD14+monocyte pairs represent dynamic cellular interactions that may contribute to inflammation and cardiometabolic disease pathogenesis and may originate or be maintained, in part, by chronic viral infections. These findings provide a foundation for future studies investigating mechanisms linking T cell-monocyte cell-cell complexes to developing immune-mediated diseases, including HIV and diabetes. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=127 SRC="FIGDIR/small/538020v2_ufig1.gif" ALT="Figure 1"> View larger version (37K): org.highwire.dtl.DTLVardef@fdc324org.highwire.dtl.DTLVardef@168fc4org.highwire.dtl.DTLVardef@138a9a0org.highwire.dtl.DTLVardef@1087108_HPS_FORMAT_FIGEXP M_FIG C_FIG HighlightsO_LICirculating CD3+ CD14+ T cell-monocyte complexes are higher in individuals with diabetes. C_LIO_LICD3+ CD14+ T cell-monocytes complexes comprise a heterogenous group of functional and dynamic cell-cell interactions. C_LIO_LIThe proportion of CD3+ CD14+ T cell-monocyte complexes is positively associated with fasting blood glucose and negatively with plasma IL-10 levels and CD4+ T regulatory cells. C_LIO_LICD3+ CD14+ T cell-monocyte complexes are metabolically flexible and can utilize both glycolysis and oxidative phosphorylation for their energy requirements. C_LIO_LIIn persons with treated HIV, CD3+ CD14+ T cell-monocytes have more detectable HIV DNA than circulating CD4+ T cells alone. C_LI
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Characterization of Distinct Monocyte Subtypes and Immune Features Associated with HIV, Tuberculosis, and Coronary Artery Disease in a Ugandan Cohort Using Mass Cytometry
José Cobeña-Reyes, Celestine N. Wanjalla, … Moises Arturo Huaman·Pathogens and ImmunityPeer-reviewed·Jan 29, 2026
- Altered glucose utilization and disrupted mitochondrial homeostasis in CD4+ T cells from HIV-positive women on combination anti-retroviral therapy
M. Akiso, M. Ameka, … M. Mureithi·bioRxiv·May 17, 2023
- CD34-positive monocytes are highly susceptible to HIV-1
Naofumi Takahashi, Osamu Noyori, … Shinya Suzu·bioRxiv·Feb 26, 2024
- Monocyte-derived Dll4 is a novel contributor to persistent systemic inflammation in HIV patients
Shumin Wang, Meera Vir Singh, … Jinjiang Pang·bioRxiv·Apr 18, 2023
- Enrichment of the HIV reservoir in CD32+ CD4 T cells occurs early in blood and tissue
- Single-cell profiling of the lung immune cells of diabetes-tuberculosis comorbidity reveals reduced type-II interferon and elevated Th17 responses.
Shweta Chaudhary, Mothe Sravya, … Ranjan Kumar Nanda·bioRxiv·Oct 24, 2024